GlaxoSmithKline S.A.E. (BIOC) Revenue
Revenue
EGP 1.62B
Fiscal year 2018
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2018 | 1.62B | 11.69% |
| 2017 | 1.45B | 24.68% |
| 2016 | 1.17B | 15.4% |
| 2015 | 1.01B | -4.89% |
| 2014 | 1.06B | 1.99% |
| 2013 | 1.04B | 13.42% |
| 2012 | 918.11M | 6.06% |
| 2011 | 865.67M | 19.1% |
| 2010 | 726.84M | 8.98% |
| 2009 | 666.95M | 4.03% |
| 2008 | 641.1M | 9.84% |
| 2007 | 583.7M | -0.96% |
| 2006 | 589.34M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.